Project Grant HT94252510510
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Switzerland
Similar Awards
The Defense Health Agency awarded a $490,602 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland. The grant, with a performance period from September 1, 2025 to August 31, 2028, will support the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. EPFL, a non-profit educational institution and state-controlled...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $499,023 to the Centre Hospitalier Universitaire Vaudois (Chuv) in Lausanne, Switzerland to support research examining the mechanisms by which spinal cord stimulation can improve motor deficits in advanced Parkinson's disease. The research project will run from September 30, 2024 to September 29, 2026. In addition, Chuv has received several other significant...
The Defense Health Agency awarded a $199,966 project grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to conduct research on the foundations supporting neuroprosthetic management of hypotensive complications in...
This Project Grant award of $568,114.00 from the Defense Health Agency was made to Ecole Polytechnique Fédérale De Lausanne (EPFL), a university in Lausanne, Switzerland, to conduct research and development related to baroprosthesis to reduce secondary damage of traumatic spinal cord injury. The award was made under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members and the public. The research...
This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,499,843.00 to Ecole Polytechnique Federale De Lausanne (EPFL) to support research on the "NEUROPROSTHETIC MANAGEMENT OF ORTHOSTATIC HYPOTENSION IN PARKINSON'S DISEASE". The award period runs from Sep 30, 2024 to Sep 29, 2027. The grant aims to advance the development of neuroprosthetic technologies to manage orthostatic hypotension, a common...
The U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) awarded a $199,908 Project Grant to the Institut National De La Sante Et De La Recherche Medicale (Inserm) to model hemangioblastomas using induced pluripotent stem cells carrying mutations in the von Hippel-Lindau gene. This 2-year project, scheduled for completion by April 30, 2026, aims to transform healthcare for Service Members and the American public through innovative biomedical research. As a...
The U.S. Defense Health Agency awarded a $989,167 Project Grant to the University of Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant, effective from February 15, 2024 to February 14, 2027, supports research to define the role of the SWI/SNF chromatin remodeling complex in advanced metastatic castration-resistant prostate cancer (mCRPC) therapy resistance. Through this grant, the University of Bern will conduct basic, translational, and...
This $485,597.91 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research at the Universite De Sherbrooke in Canada. The award will fund a 3-year project from August 1, 2024 to July 31, 2027 focused on understanding the "CONTRIBUTION OF ALTERNATIVE SPLICING TO NEUROFIBROMAGENESIS." The research aims to advance scientific knowledge in the area of neurological disorders, which...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...